News
SINT
2.740
+0.43%
0.012
SiNtx Technologies Initiated at Buy by HC Wainwright & Co.
Dow Jones · 3d ago
SiNtx Technologies Price Target Announced at $10.00/Share by HC Wainwright & Co.
Dow Jones · 3d ago
HC Wainwright & Co. Initiates Coverage On SINTX Technologies with Buy Rating, Announces Price Target of $10
Benzinga · 3d ago
Weekly Report: what happened at SINT last week (0406-0410)?
Weekly Report · 3d ago
Sintx Technologies initiated with a Buy at H.C. Wainwright
TipRanks · 3d ago
SINTX TECHNOLOGIES, INC. <SINT.O>: H.C. WAINWRIGHT INITIATES COVERAGE WITH BUY RATING
Reuters · 3d ago
U.S. RESEARCH ROUNDUP-Chevron, Ford, Occidental Petroleum
Reuters · 3d ago
SiNtx Technologies Is Maintained at Buy by Ascendiant Capital
Dow Jones · 04/08 10:03
SiNtx Technologies Price Target Cut to $12.00/Share From $16.00 by Ascendiant Capital
Dow Jones · 04/08 10:03
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $12
Benzinga · 04/08 09:55
Weekly Report: what happened at SINT last week (0330-0403)?
Weekly Report · 04/06 10:34
Weekly Report: what happened at SINT last week (0323-0327)?
Weekly Report · 03/30 10:34
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 03/23 21:05
BUZZ-U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla
Reuters · 03/23 15:58
BUZZ-SINTX rises after first use of FDA-cleared implant, names new president
Reuters · 03/23 13:59
SINTX Releases Corporate Update On Key Milestones, Including First Human Surgical Procedure Using FDA-Approved Foot & Ankle Osteotomy Wedge System
Benzinga · 03/23 13:20
SINTX TECHNOLOGIES PROVIDES CORPORATE BUSINESS UPDATE HIGHLIGHTING FIRST HUMAN IMPLANT, STRATEGIC TRANSFORMATION, AND COMMERCIAL EXECUTION
Reuters · 03/23 13:15
Weekly Report: what happened at SINT last week (0316-0320)?
Weekly Report · 03/23 10:30
SINTX Technologies FY 2025 net loss was USD 10.4 million as total revenue fell 65% to USD 1.02 million
Reuters · 03/20 21:02
SINTX Technologies Completes First-In-Human Surgical Procedure Utilizing FDA-Cleared SINAPTIC Foot & Ankle Osteotomy Wedge System
Benzinga · 03/19 11:39
More
Webull provides a variety of real-time SINT stock news. You can receive the latest news about Sintx Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About SINT
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.